DK1680405T3 - Bengamidderivater og deres anvendelse til behandling af kræftsygdomme - Google Patents

Bengamidderivater og deres anvendelse til behandling af kræftsygdomme

Info

Publication number
DK1680405T3
DK1680405T3 DK04765884T DK04765884T DK1680405T3 DK 1680405 T3 DK1680405 T3 DK 1680405T3 DK 04765884 T DK04765884 T DK 04765884T DK 04765884 T DK04765884 T DK 04765884T DK 1680405 T3 DK1680405 T3 DK 1680405T3
Authority
DK
Denmark
Prior art keywords
treatment
cancer diseases
bengamide derivatives
bengamide
derivatives
Prior art date
Application number
DK04765884T
Other languages
Danish (da)
English (en)
Inventor
Holger Hoffmann
Sabine Haag-Richter
Michael Kurz
Heiko Tietgen
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1680405T3 publication Critical patent/DK1680405T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK04765884T 2003-10-24 2004-10-08 Bengamidderivater og deres anvendelse til behandling af kræftsygdomme DK1680405T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10349669A DE10349669B3 (de) 2003-10-24 2003-10-24 Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
PCT/EP2004/011244 WO2005044803A1 (de) 2003-10-24 2004-10-08 Bengamide-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krebserkrankungen

Publications (1)

Publication Number Publication Date
DK1680405T3 true DK1680405T3 (da) 2009-05-04

Family

ID=34484998

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04765884T DK1680405T3 (da) 2003-10-24 2004-10-08 Bengamidderivater og deres anvendelse til behandling af kræftsygdomme

Country Status (29)

Country Link
EP (2) EP1680405B1 (pt)
JP (1) JP4769190B2 (pt)
KR (1) KR20060120044A (pt)
CN (2) CN101294173A (pt)
AR (1) AR046553A1 (pt)
AT (2) ATE420074T1 (pt)
AU (1) AU2004287561B2 (pt)
BR (1) BRPI0415529A (pt)
CA (1) CA2543003A1 (pt)
CL (1) CL2009000674A1 (pt)
CY (1) CY1110458T1 (pt)
DE (3) DE10349669B3 (pt)
DK (1) DK1680405T3 (pt)
ES (1) ES2320894T3 (pt)
HR (1) HRP20090187T1 (pt)
IL (1) IL174524A (pt)
MA (1) MA28213A1 (pt)
ME (1) MEP33108A (pt)
MX (1) MXPA06004084A (pt)
NO (1) NO20062149L (pt)
NZ (1) NZ546744A (pt)
PL (1) PL1680405T3 (pt)
PT (1) PT1680405E (pt)
RS (1) RS20060263A (pt)
RU (1) RU2357956C2 (pt)
SI (1) SI1680405T1 (pt)
UY (1) UY28574A1 (pt)
WO (1) WO2005044803A1 (pt)
ZA (1) ZA200602231B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2878525B1 (fr) * 2004-11-29 2007-02-23 Aventis Pharma Sa Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
FR2878528B1 (fr) 2004-11-29 2008-05-16 Aventis Pharma Sa 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
FR2901555A1 (fr) 2006-05-24 2007-11-30 Sanofi Aventis Sa 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation
FR2901556A1 (fr) 2006-05-24 2007-11-30 Sanofi Aventis Sa Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation
FR2901554B1 (fr) 2006-05-24 2011-04-01 Sanofi Aventis 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK173287A (da) * 1986-04-04 1987-10-05 Sankyo Co Perhydrothiazepin- og perhydroazepinderivater og fremgangsmaade til fremstilling deraf
CO5140099A1 (es) * 1998-11-17 2002-03-22 Novartis Ag Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores
ES2299515T3 (es) * 2000-05-11 2008-06-01 Novartis Ag Carbonatos y eteres de caprolactama sustituidos y su uso como agentes antitumorales.
JP2004262793A (ja) * 2003-02-28 2004-09-24 Noyaku Bio Technology Kaihatsu Gijutsu Kenkyu Kumiai 化合物ｎ−９０１１、その製造法及び用途
CN1856486A (zh) * 2003-07-25 2006-11-01 诺瓦提斯公司 取代的内酰胺和它们作为抗癌剂的用途

Also Published As

Publication number Publication date
ZA200602231B (en) 2007-06-27
JP4769190B2 (ja) 2011-09-07
NO20062149L (no) 2006-07-11
MA28213A1 (fr) 2006-10-02
CA2543003A1 (en) 2005-05-19
UY28574A1 (es) 2005-05-31
EP1873146B1 (de) 2010-08-11
EP1680405B1 (de) 2009-01-07
ES2320894T3 (es) 2009-05-29
DE502004008837D1 (de) 2009-02-26
CN100398520C (zh) 2008-07-02
DE502004011536D1 (de) 2010-09-23
BRPI0415529A (pt) 2006-12-26
AU2004287561B2 (en) 2011-06-02
RS20060263A (sr) 2008-09-29
SI1680405T1 (sl) 2009-06-30
JP2007509084A (ja) 2007-04-12
KR20060120044A (ko) 2006-11-24
DE10349669B3 (de) 2005-05-25
CL2009000674A1 (es) 2009-08-07
ATE420074T1 (de) 2009-01-15
PL1680405T3 (pl) 2009-06-30
IL174524A0 (en) 2006-08-01
CY1110458T1 (el) 2015-04-29
IL174524A (en) 2012-08-30
RU2357956C2 (ru) 2009-06-10
CN1871217A (zh) 2006-11-29
AR046553A1 (es) 2005-12-14
CN101294173A (zh) 2008-10-29
RU2006117769A (ru) 2007-11-27
EP1873146A2 (de) 2008-01-02
HK1098131A1 (zh) 2007-07-13
ATE477244T1 (de) 2010-08-15
PT1680405E (pt) 2009-03-31
EP1680405A1 (de) 2006-07-19
MEP33108A (en) 2010-10-10
HRP20090187T1 (en) 2009-05-31
WO2005044803A1 (de) 2005-05-19
EP1873146A3 (de) 2008-05-21
MXPA06004084A (es) 2006-06-27
AU2004287561A1 (en) 2005-05-19
NZ546744A (en) 2009-03-31

Similar Documents

Publication Publication Date Title
DK1917246T3 (da) Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme
IS7977A (is) Samsetningar og aðferð til samsettra meðferðar
DK1578755T3 (da) Phosphonooxyguinalinderivater og deres farmaceutiske anvendelse
DK1673104T4 (da) Fremføring af terapeutiske forbindelser til hjernen og andre væv
DK1678194T3 (da) Modulering af syntese og degradering af hyaluronan i behandlingen af sygdom
DK1663978T3 (da) Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
DK1615909T3 (da) Piperazin-derivater og deres anvendelse til behandling af neurologiske og psykiatriske sygdomme
DK1944322T3 (da) Behandling af TNFalfa-relaterede sygdomme
DK1392292T3 (da) Pyranoindazoler og deres anvendelse til behandling af glaukom
IS8305A (is) Bindandi smíðar og aðferðir við notkun þeirra
EE05505B1 (et) Personaalne teraapiasektsioon
DK1537096T3 (da) Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf
NO20055246D0 (no) Heteroaromatisk pentasyklisk forbindelse og medisinsk anvendelse derav
IS7348A (is) N-pýrasínýl-fenýlsúlfónamíð og notkun þeirra til að meðhöndla flakkboðatengda sjúkdóma
NO20055204D0 (no) Derivater av piperidinyl- og pipemzinylalkylkarbamater, fremgangsmater for fremstilling derav og anvendelse av de samme i terapi
ATE479437T1 (de) Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung
DK1928457T3 (da) Quinoliner og deres terapeutiske anvendelse
DK1575951T3 (da) Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
IS8329A (is) Kínólínafleiður og notkun þeirra í meðferð
DK1513835T3 (da) Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
DK1432417T3 (da) Substituerede imidazolforbindelser og deres anvendelse til behandling af cancer
DK1590321T3 (da) Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma